RWE4Decisions is a multi-stakeholder initiative commissioned by the Belgian National Institute of Health and Disability Insurance (INAMI-RIZIV) and bringing together policy-makers, health technology assessment (HTA) bodies, healthcare payers, regulatory agencies, clinicians, patient groups, researchers, registry-holders, data analysts, industry, and academic experts.
Its mission is to identify the best ways to collect and use fit-for-purpose real-world evidence (RWE) across the life cycle of highly innovative medicines, in order to support decision-making for highly innovative technologies.